Literature DB >> 11238995

Fully modified 2' MOE oligonucleotides redirect polyadenylation.

T A Vickers1, J R Wyatt, T Burckin, C F Bennett, S M Freier.   

Abstract

Many genes have been described and characterized that have alternative polyadenylation signals at the 3'-end of their pre-mRNAs. Many of these same messages also contain destabilization motifs responsible for rapid degradation of the mRNA. Polyadenylation site selection can thus determine the stability of an mRNA. Fully modified 2'-O:-methoxy ethyl/phosphorothioate oligonucleotides that hybridize to the 3'-most polyadenylation site or signal of E-selectin were able to inhibit polyadenylation at this site and redirect it to one of two upstream cryptic sites. The shorter transcripts produced after antisense treatment have fewer destabilization sequences, increased mRNA stability and altered protein expression. This study demonstrates that antisense oligonucleotides can be successfully employed to redirect polyadenylation. This is the first demonstration of the use of oligonucleotides to increase, rather than decrease, abundance of a message.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238995      PMCID: PMC29745          DOI: 10.1093/nar/29.6.1293

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  26 in total

Review 1.  Novel mechanisms for antisense-mediated regulation of gene expression.

Authors:  B F Baker; B P Monia
Journal:  Biochim Biophys Acta       Date:  1999-12-10

2.  Patterns of variant polyadenylation signal usage in human genes.

Authors:  E Beaudoing; S Freier; J R Wyatt; J M Claverie; D Gautheret
Journal:  Genome Res       Date:  2000-07       Impact factor: 9.043

3.  Identification of an inducible endothelial-leukocyte adhesion molecule.

Authors:  M P Bevilacqua; J S Pober; D L Mendrick; R S Cotran; M A Gimbrone
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

4.  Function of ribonuclease H in initiation of DNA replication in Escherichia coli K-12.

Authors:  T Kogoma; N L Subia; K von Meyenburg
Journal:  Mol Gen Genet       Date:  1985

5.  Effects of RNA secondary structure on cellular antisense activity.

Authors:  T A Vickers; J R Wyatt; S M Freier
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

6.  Patterns of polyadenylation site selection in gene constructs containing multiple polyadenylation signals.

Authors:  R M Denome; C N Cole
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

7.  A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.

Authors:  G Shaw; R Kamen
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

8.  In vitro transcriptional and translational block of the bcl-2 gene operated by peptide nucleic acid.

Authors:  L Mologni; P E Nielsen; C Gambacorti-Passerini
Journal:  Biochem Biophys Res Commun       Date:  1999-10-22       Impact factor: 3.575

Review 9.  3'-End processing of pre-mRNA in eukaryotes.

Authors:  E Wahle; U Rüegsegger
Journal:  FEMS Microbiol Rev       Date:  1999-06       Impact factor: 16.408

10.  Physicochemical properties of phosphorothioate oligodeoxynucleotides.

Authors:  C A Stein; C Subasinghe; K Shinozuka; J S Cohen
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

View more
  25 in total

Review 1.  Antisense technology: an overview and prospectus.

Authors:  Stanley T Crooke; Brenda F Baker; Rosanne M Crooke; Xue-Hai Liang
Journal:  Nat Rev Drug Discov       Date:  2021-03-24       Impact factor: 84.694

2.  Upregulation of functional Kv11.1 isoform expression by inhibition of intronic polyadenylation with antisense morpholino oligonucleotides.

Authors:  Qiuming Gong; Matthew R Stump; Zhengfeng Zhou
Journal:  J Mol Cell Cardiol       Date:  2014-08-14       Impact factor: 5.000

Review 3.  Antisense technology: A review.

Authors:  Stanley T Crooke; Xue-Hai Liang; Brenda F Baker; Rosanne M Crooke
Journal:  J Biol Chem       Date:  2021-02-16       Impact factor: 5.157

4.  Steric inhibition of human immunodeficiency virus type-1 Tat-dependent trans-activation in vitro and in cells by oligonucleotides containing 2'-O-methyl G-clamp ribonucleoside analogues.

Authors:  Stephen C Holmes; Andrey A Arzumanov; Michael J Gait
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

Review 5.  Antisense oligonucleotides: treating neurodegeneration at the level of RNA.

Authors:  Sarah L DeVos; Timothy M Miller
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

Review 6.  Antisense oligonucleotides: the next frontier for treatment of neurological disorders.

Authors:  Carlo Rinaldi; Matthew J A Wood
Journal:  Nat Rev Neurol       Date:  2017-12-01       Impact factor: 42.937

Review 7.  Antisense Oligonucleotide Therapies for Neurodegenerative Diseases.

Authors:  C Frank Bennett; Adrian R Krainer; Don W Cleveland
Journal:  Annu Rev Neurosci       Date:  2019-07-08       Impact factor: 12.449

Review 8.  Antisense Drugs Make Sense for Neurological Diseases.

Authors:  C Frank Bennett; Holly B Kordasiewicz; Don W Cleveland
Journal:  Annu Rev Pharmacol Toxicol       Date:  2020-10-09       Impact factor: 13.820

9.  siRNAs targeted to certain polyadenylation sites promote specific, RISC-independent degradation of messenger RNAs.

Authors:  Timothy A Vickers; Stanley T Crooke
Journal:  Nucleic Acids Res       Date:  2012-03-15       Impact factor: 16.971

Review 10.  Cell type-specific microRNA therapies for myocardial infarction.

Authors:  Bohao Liu; Bryan Wang; Xiaokan Zhang; Roberta Lock; Trevor Nash; Gordana Vunjak-Novakovic
Journal:  Sci Transl Med       Date:  2021-02-10       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.